Surgery Partners (SGRY) Long-Term Investments (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Long-Term Investments data on file, last reported at $225.4 million in Q1 2026.

• Quarterly Long-Term Investments rose 3.11% year-over-year to $225.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $225.4 million (up 3.11% YoY) and the FY2025 annual result came in at $234.0 million, up 8.64% from the prior year.
• Long-Term Investments retreated to $225.4 million in Q1 2026 per SGRY's latest filing, from $234.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $234.0 million in Q4 2025, with the low at $94.5 million in Q1 2022.
• Average Long-Term Investments over 5 years is $198.3 million, with a median of $196.3 million recorded in 2023.
• Year-over-year, Long-Term Investments surged 114.54% in 2022 and retreated 3.26% in 2023.
• Surgery Partners' Long-Term Investments stood at $190.3 million in 2022, then slipped by 3.26% to $184.1 million in 2023, then gained by 17.0% to $215.4 million in 2024, then advanced by 8.64% to $234.0 million in 2025, then slipped by 3.68% to $225.4 million in 2026.
• Business Quant data shows SGRY's Long-Term Investments at $225.4 million in Q1 2026, $234.0 million in Q4 2025, and $229.4 million in Q3 2025.